Nahdi Medical Company Nahdi Medical Company

Nahdi Medical Company

4164

Hisse Senetlerindeki Sıralama #4835
Nahdi Medical Company stands as a prominent pharmaceutical retail chain with... Nahdi Medical Company stands as a prominent pharmaceutical retail chain with operations spanning both the Kingdom of Saudi Arabia and the United Arab Emirates. Its extensive product portfolio encompasses a diverse range of pharmaceutical goods, health and wellness items, maternal and infant care essentials, beauty products, and various fast-moving consumer goods. Beyond retail, Nahdi provides a comprehensive suite of omni-health services, including polyclinics, rapid-care clinics, telemedicine platforms, laboratory facilities, and home healthcare programs. The company is also actively involved in the wholesale and retail distribution of cosmetics, medicines, specialized dietary products, healthy food options, and medical equipment. With approximately 1,151 pharmacies under its management, Nahdi Medical Company was established in 1986 and maintains its headquarters in Jeddah, Saudi Arabia. It operates as a subsidiary under the umbrella of both Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.
Hisse Fiyatı
$23.46
Piyasa Değeri
$3.05B
Değişim (1 gün)
-0.28%
Değişim (1 yıl)
-26.97%
Ülke
SA
Ticaret Nahdi Medical Company (4164)

Kategori

Healthcare
Nahdi Medical Company (4164) için kazanç
Jun 2026 itibarıyla kazanç TTM: $217.74M
Nahdi Medical Company şirketinin en son finansal raporlarına göre, mevcut kazancı $217.74M'dir. 2023 yılında şirket $251.81M kazanç elde etti, bu 2022 yılındaki $249.53M kazanca göre önceki yıla göre artış. Bu sayfada gösterilen kazanç, faiz ve vergiler öncesi kazançtır; yani EBIT.
Nahdi Medical Company için kazanç geçmişi 2017 - 2026
Her yılın sonundaki kazanç
Yıl Kazanç Değiştir
2026 (TTM) $217.74M -1.98%
2024 $222.14M -11.78%
2023 $251.81M 0.91%
2022 $249.53M 9.27%
2021 $228.35M -4.23%
2020 $238.42M 16.36%
2019 $204.91M 20.34%
2018 $170.27M -15.09%
2017 $200.53M 0.00%
Benzer şirketler veya rakipler için kazanç